17969-36-7 Usage
Uses
Used in Pharmaceutical Development:
2-(4-chlorophenyl)-4-thiazoleacetamide is used as a potential active ingredient for the development of new pharmaceuticals, due to its demonstrated antifungal and antimicrobial properties. These properties could be harnessed in the creation of treatments for various infections and diseases.
Used in Agrochemical Production:
In the agrochemical industry, 2-(4-chlorophenyl)-4-thiazoleacetamide is used as a potential component in the formulation of pesticides and fungicides. Its antifungal and antimicrobial properties make it a candidate for protecting crops from harmful pathogens and pests.
Used in Organic Synthesis:
2-(4-chlorophenyl)-4-thiazoleacetamide is used as a building block in organic synthesis for the creation of more complex molecules. Its unique structure and functional groups make it a valuable intermediate in the synthesis of a variety of chemical products, including specialty chemicals and advanced materials.
Used in Chemical Product Development:
2-(4-chlorophenyl)-4-thiazoleacetamide is used as a potential component in the development of other chemical products, such as dyes, coatings, and plastics. Its versatility and potential reactivity in chemical reactions make it a candidate for improving the properties of these materials or for creating new products with unique characteristics.
Check Digit Verification of cas no
The CAS Registry Mumber 17969-36-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,9,6 and 9 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 17969-36:
(7*1)+(6*7)+(5*9)+(4*6)+(3*9)+(2*3)+(1*6)=157
157 % 10 = 7
So 17969-36-7 is a valid CAS Registry Number.
17969-36-7Relevant academic research and scientific papers
MUTANT IDH1 INHIBITORS USEFUL FOR TREATING CANCER
-
Paragraph 0110, (2016/07/27)
Compounds of Formula I and Formula II and the pharmaceutically acceptable salts thereof are disclosed The variables A, B, Y, Z, X1, X2, R1-4 and R13-18 are disclosed herein. The compounds are useful for treating cancer disorders, especially those involving mutant IDH1 enzymes. Pharmaceutical compositions containing compounds of Formula I or Formula II and methods of treatment comprising administering compounds of Formula I and Formula II are also disclosed.
